BackAltamira Therapeutics Overview

Altamira Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CYTO.

Quarterly EBIT

-$2.71M
↑ 35.71% YoY

As of Jun 30, 2023

Annual EBIT (TTM)

-$2.61M
↑ 64.23% YoY

Trailing 12 months ending Jun 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin